Safety of biologics in severe asthmatic patients with SARS‐CoV‐2 infection: A prospective study
Sign Up to like & getrecommendations! Published in 2023 at "Pediatric Pulmonology"
DOI: 10.1002/ppul.26298
Abstract: Asthma guidelines have recommended continuing treatment with biologics during coronavirus disease 2019 (COVID‐19) pandemic. However, a continuation of treatment with biologics in patients with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has been little investigated. read more here.
Keywords: asthmatic patients; safety biologics; severe asthmatic; patients sars ... See more keywords
Biologics in severe asthma: Outcomes in clinical trials-Similarities and differences
Sign Up to like & getrecommendations! Published in 2022 at "Expert Opinion on Biological Therapy"
DOI: 10.1080/14712598.2022.2091409
Abstract: ABSTRACT Introduction Severe asthma is a heterogenous disease characterized by multiple phenotypes. Targeted biologic therapies have revolutionarily changed the management of severe asthma by affecting various clinical outcomes, mainly by reducing exacerbations and the use… read more here.
Keywords: asthma outcomes; clinical trials; outcomes clinical; similarities differences ... See more keywords
Biologics and severe asthma in children
Sign Up to like & getrecommendations! Published in 2022 at "Current Opinion in Allergy and Clinical Immunology"
DOI: 10.1097/aci.0000000000000880
Abstract: Purpose of review Severe asthma can carry significant morbidity and mortality for patients, and it places a burden on families and the healthcare system. Biologic agents have revolutionized the care of patients with severe asthma… read more here.
Keywords: asthma; severe asthma; asthma children; biologics severe ... See more keywords
Biologics for severe asthma-Which, when and why?
Sign Up to like & getrecommendations! Published in 2023 at "Respirology"
DOI: 10.1111/resp.14520
Abstract: Asthma is a common chronic inflammatory condition of the airways that affects about 350 million people globally. In 5%-10% of individuals, it is severe, with considerable morbidity and high health care utilization. The goal of… read more here.
Keywords: severe asthma; asthma; biologics severe; asthma biologics ... See more keywords
Biologics in severe asthma: the role of real-world evidence from registries
Sign Up to like & getrecommendations! Published in 2022 at "European Respiratory Review"
DOI: 10.1183/16000617.0278-2021
Abstract: Asthma is one of the most common noncommunicable diseases; in the majority of patients it is well controlled with inhaled bronchodilators and inhaled corticosteroids, but the management of severe asthma has been a significant challenge… read more here.
Keywords: asthma role; real life; evidence; severe asthma ... See more keywords
Heterogeneity in the use of biologics for severe asthma in Europe: a SHARP ERS study
Sign Up to like & getrecommendations! Published in 2022 at "ERJ Open Research"
DOI: 10.1183/23120541.00273-2022
Abstract: Introduction Treatment with biologics for severe asthma is informed by international and national guidelines and defined by national regulating bodies, but how these drugs are used in real-life is unknown. Materials and methods The European… read more here.
Keywords: use biologics; europe; heterogeneity use; severe asthma ... See more keywords